All filters
Abstracts
Alarming burden of Dual-Class HIV-1 Drug Resistance among Adolescents calls for innovative Antiretroviral Strategies: Baseline findings from the Ready-Study (EDCTP TMA 1027)
A. Nangmo
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Striving towards HIV epidemic control through reaching a population in correctional facilities in Namibia
H. Ashivudhi
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Stakeholder participation in the establishment of One-stop shops and Key Population-friendly facilities: descriptive lessons from the FHI 360 GF project
C. Oraelosi
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Intensified Active tracking of clients lost to follow-up from HIV Care: Experiences from an HIV program in south-central Uganda.
Kisakye
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Prevalence, risk and protective factors for common mental disorders among young people living with HIV compared to their uninfected peers from the Kenyan Coast: A cross sectional study
M. Nyongesa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Organisation du financement du dépistage du VIH à base communautaire en Côte d'Ivoire : une recherche d'efficience potentiellement contre-productive?
A. Assoumou
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Cost of antiretroviral therapy services among patients who achieved viral suppression: A case study of 9 ART clinics in Namibia
N. Hamunime
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Using a Quality Improvement Collaborative Approach to Improve Tuberculosis prevention therapy coverage in the Kavango region, Namibia.
A. Basenero
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
It is better if you are going to test yourself…”: attitudes, test preferences and challenges of HIV self-testing among female sex workers in eThekwini, South Africa: the Siyaphanta study
K. Sithole
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Case Series of Urethrocutaneous Fistulas After Voluntary Medical Male Circumcision for HIV Prevention—15 African Countries, 2015–2019
T. Lucas
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Association between DREAMS interventions and HIV risk behaviors of young women’s male sex partners in Rakai, Uganda
A. Ssettuba
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Current approaches for identifying and managing HIV treatment failure among children, adolescents, and young people in sub-Saharan Africa: Multi-country experience from the New Horizons Collaborative
N. Rakhmanina
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Traditional healers can increase uptake of HIV testing among adults of unknown serostatus: results from a cluster randomized pilot study in southwestern Uganda
R. Sundararajan
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Positive Effects of Intensified Preventive Calls/Home Visits on Early Retention Among Adults Newly Initiated on Antiretroviral Therapy in Zambézia Province, Mozambique
C. De Schacht
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
DTG+3TC vs DTG+TDF/FTC (GEMINI-1&-2): Confirmed Virologic Withdrawals Through Week 96
J. van Wyk
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Does Dolutegravir causes weight gain: a retrospective observational cohort study from Lusaka, Zambia
D. Mwamba
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: 96-week results of the ANRS 12313 – NAMSAL trial
C. Kouanfack
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Doing Index Testing differently: A health education approach for old clients returning for refill and those newly initiating ART to effectively participate in index testing.
P. Nji Atanga
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Effectiveness of male Strategy (MS) in HIV case identification and linkage of MLHIV to treatment in Cameroon.
E. Njemkerk
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
A Hybrid Interpersonal Training Model to build Capacity for Health-Care-Providers (HITCH) to Manage Children, Adolescents and Adults on Third-Line Anti-Retro Viral (ART) Therapy in Uganda.
E. Magongo
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen Through 48 Weeks: Subgroup Analyses From the TANGO Study
J. van Wyk
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Optimizing HIV Treatment among Children in Mozambique
M. Tomo De Deus
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Impact of community resource persons and mobile phone technology on return to HIV care among loss to follow up HIV clients in 104 HIV facilities in Uganda
A. Mugisa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
U=U - Catalyst or Barrier for Men's Engagement in ART? Stakeholder Views from Blantyre, Malawi
A. Berner-Rodoreda
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020